HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Tanja Skyttä Selected Research
Tanja Skyttä Research Topics
Disease
19
Breast Neoplasms (Breast Cancer)
07/2023 - 11/2014
8
Unilateral Breast Neoplasms
08/2019 - 03/2015
5
Melanoma (Melanoma, Malignant)
01/2023 - 05/2009
5
Neoplasms (Cancer)
01/2023 - 05/2009
2
Fibrosis (Cirrhosis)
07/2023 - 06/2021
2
Neoplasm Metastasis (Metastasis)
10/2022 - 05/2009
2
Cardiotoxicity
02/2020 - 12/2017
2
Noninfiltrating Intraductal Carcinoma (DCIS)
10/2018 - 07/2015
1
Heart Failure
07/2023
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023
1
Myocarditis (Carditis)
04/2020
1
Non-ST Elevated Myocardial Infarction
03/2018
1
AIDS-Related Complex (ARC)
01/2016
1
Hodgkin Disease (Hodgkin's Disease)
01/2015
1
Heart Diseases (Heart Disease)
01/2015
1
Disease Progression
10/2011
Drug/Important Bio-Agent (IBA)
4
Biomarkers (Surrogate Marker)
IBA
10/2022 - 10/2011
2
Cytokines
IBA
01/2021 - 10/2018
2
Interferon-alpha (Interferon Alfa)
IBA
03/2020 - 05/2009
2
Aromatase Inhibitors
IBA
08/2019 - 03/2015
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2023
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2023
1
Ado-Trastuzumab Emtansine
IBA
01/2023
1
Immunoconjugates (Immunoconjugate)
IBA
01/2023
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
10/2022
1
Circulating Tumor DNA
IBA
10/2022
1
RNA (Ribonucleic Acid)
IBA
01/2021
1
N 30
IBA
01/2021
1
Scavenger Receptors (Scavenger Receptor)
IBA
01/2021
1
Antibodies
IBA
01/2021
1
bexmarilimab
IBA
01/2021
1
Lipids
IBA
01/2021
1
Immunoglobulin G (IgG)
IBA
01/2021
1
Immune Checkpoint Inhibitors
IBA
04/2020
1
Vincristine (Oncovin)
FDA Link
Generic
03/2020
1
Lomustine (CCNU)
FDA Link
03/2020
1
Temozolomide (Temodar)
FDA Link
Generic
03/2020
1
Vemurafenib
IBA
03/2020
1
Transforming Growth Factor beta (TGF-beta)
IBA
08/2019
1
Homoarginine
IBA
12/2017
1
Troponin T (Troponin T1)
IBA
07/2015
1
Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)
IBA
10/2011
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
10/2011
1
Bevacizumab (Avastin)
FDA Link
10/2011
1
Carboplatin (JM8)
FDA Link
Generic
05/2009
1
Interleukin-2 (IL2)
IBA
05/2009
1
Vinorelbine (Navelbine)
FDA Link
Generic
05/2009
1
Dacarbazine (DIC)
FDA Link
Generic
05/2009
1
Vinca Alkaloids
IBA
05/2009
1
Platinum
IBA
05/2009
Therapy/Procedure
16
Radiotherapy
07/2023 - 11/2014
10
Adjuvant Radiotherapy
01/2021 - 03/2015
7
Drug Therapy (Chemotherapy)
06/2021 - 05/2009
2
Immunotherapy
01/2023 - 01/2021
2
Therapeutics
10/2011 - 05/2009
1
Combination Drug Therapy (Combination Chemotherapy)
03/2020
1
Length of Stay
03/2018
1
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
10/2016